Related Experiment Video
Updated: Mar 19, 2026

07:01
Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
Published on: March 1, 2020
10.9K
High-Throughput Single-Cell Derived Sphere Formation for Cancer Stem-Like Cell Identification and Analysis
Yu-Chih Chen1,2, Patrick N Ingram3, Shamileh Fouladdel2
1Department of Electrical Engineering and Computer Science, University of Michigan, 1301 Beal Avenue, Ann Arbor, MI 48109-2122, USA.
Scientific Reports
|June 14, 2016
Summary
This study introduces a microfluidic platform for high-throughput identification of cancer stem-like cells (CSCs). The system enables single-cell analysis of CSCs, aiding in understanding tumor heterogeneity and developing targeted therapies.
Area of Science:
- Oncology
- Biotechnology
- Microfluidics
Background:
- Malignancies are often driven by cancer stem-like cells (CSCs) with stem cell properties.
- Current CSC identification methods (markers, enzymatic activity) face limitations due to heterogeneity and plasticity.
- In-vitro sphere formation is a viable method but is labor-intensive and low-throughput.
Purpose of the Study:
- To develop a high-throughput microfluidic platform for single-cell derived sphere formation.
- To enable reliable identification and downstream clonal analysis of cancer stem-like cells (CSCs).
- To overcome limitations of existing CSC detection methods.
Main Methods:
- A 1,024-microchamber microfluidic device was engineered for single-cell capture and sphere formation.
- Hydrodynamic focusing was employed to achieve high single-cell occupancy (>70%).
- Single-cell derived spheres were retrieved for dissociation and analysis using a 96-gene panel.
Main Results:
- The microfluidic platform successfully facilitated single-cell derived sphere formation from heterogeneous cancer cell populations.
- High single-cell capture efficiency allowed for monitoring of CSC sphere formation.
- Downstream analysis of clonal CSC spheres revealed intra-tumor heterogeneity.
Conclusions:
- The developed microfluidic platform offers a reliable and high-throughput solution for CSC identification.
- This technology supports detailed clonal analysis of CSCs, advancing cancer stem cell research.
- The platform facilitates a deeper understanding of tumor heterogeneity and CSC biology.

